Cargando…
Directed evolution of potent neutralizing nanobodies against SARS-CoV-2 using CDR-swapping mutagenesis
There is widespread interest in facile methods for generating potent neutralizing antibodies, nanobodies, and other affinity proteins against SARS-CoV-2 and related viruses to address current and future pandemics. While isolating antibodies from animals and humans are proven approaches, these method...
Autores principales: | Zupancic, Jennifer M., Desai, Alec A., Schardt, John S., Pornnoppadol, Ghasidit, Makowski, Emily K., Smith, Matthew D., Kennedy, Andrew A., Garcia de Mattos Barbosa, Mayara, Cascalho, Marilia, Lanigan, Thomas M., Tai, Andrew W., Tessier, Peter M. |
---|---|
Formato: | Online Artículo Texto |
Lenguaje: | English |
Publicado: |
Elsevier Ltd.
2021
|
Materias: | |
Acceso en línea: | https://www.ncbi.nlm.nih.gov/pmc/articles/PMC8223476/ https://www.ncbi.nlm.nih.gov/pubmed/34171229 http://dx.doi.org/10.1016/j.chembiol.2021.05.019 |
Ejemplares similares
-
Facile isolation of high-affinity nanobodies from synthetic libraries using CDR-swapping mutagenesis
por: Zupancic, Jennifer M., et al.
Publicado: (2022) -
Discovery and characterization of high-affinity, potent SARS-CoV-2 neutralizing antibodies via single B cell screening
por: Schardt, John S., et al.
Publicado: (2021) -
A hybridoma-derived monoclonal antibody with high homology to the aberrant myeloma light chain
por: Pornnoppadol, Ghasidit, et al.
Publicado: (2021) -
Highly Efficient Targeted Mutagenesis of Drosophila with the CRISPR/Cas9 System
por: Bassett, Andrew R., et al.
Publicado: (2013) -
38227 Specific and highly potent human monoclonal antibodies against SARS-CoV-2
por: de Mattos Barbosa, Mayara Garcia, et al.
Publicado: (2021)